Crohn’s Disease and Axial Spondyloarthritis: From Systemic Inflammation to Amyloidosis
Journal of Clinical Medicine · 28.05.2026 · 15 (11) · 4188
DOI: 10.3390/jcm15114188 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.05.2026. Verfasst von Daria Alexeevna Kutsakina und 10 weiteren Autor:innen. Beteiligte Einrichtung: Hospital Therapy No. 1, Sechenov First Moscow State Medical University, Moscow 119991, Russia. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Crohn‘s disease (CD) is frequently complicated by extraintestinal manifestations, including axial spondyloarthritis (axSpA). Both diseases share genetic (HLA-B27, IL23R, ERAP1/2) and immunopathological mechanisms (Th17/IL-23 axis). Their co-occurrence increases the risk of systemic complications such as AA amyloidosis. Case presentation: We report a 42-year-old male with HLA-B27-positive axSpA who developed CD shortly after initiating secukinumab (IL-17A inhibitor). Following discontinuation of secukinumab and surgical management of CD, the patient experienced rapidly progressive AA amyloidosis affecting the kidneys and intestines, leading to acute kidney injury and requiring hemodialysis. Potential triggering factors included a preceding intestinal infection and self-administered infrared physiotherapy.
Conclusions
Coexistent CD and axSpA significantly increases the risk of severe AA amyloidosis. IL-17 inhibitors should be used with extreme caution in patients with subclinical or active CD. Early screenings for proteinuria and low-threshold biopsy are essential to detect AA amyloidosis. In patients with both conditions, TNF-α or IL-12/23 inhibitors are preferred over IL-17 blockade.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hospital Therapy No. 1, Sechenov First Moscow State Medical University, Moscow 119991, Russia.
- Faculty Surgery No. 1, Sechenov First Moscow State Medical University, Moscow 119991, Russia.
- Faculty Therapy No. 1, Sechenov First Moscow State Medical University, Moscow 119991, Russia.
ORCID-Profile: Daria Alexeevna Kutsakina, Alexandra Dmitrievna Chernichkina, Nadezhda Andreevna Nikolaeva, Olga Olegovna Voronkova, Olga Valerevna Tashchyan, Marina Genrikovna Mnatsakanyan, Yuri Nikitich Belenkov, Sergey Viktorovich Osminin, Fedor Petrovich Vetshev, Ildar Ravilievich Bilyalov, Alexander Sergeevich Panferov
Zitieren
APA
Kutsakina, D. A., Chernichkina, A. D., Nikolaeva, N. A., Voronkova, O. O., Tashchyan, O. V., Mnatsakanyan, M. G., Belenkov, Y. N., Osminin, S. V., Vetshev, F. P., Bilyalov, I. R., & Panferov, A. S. (2026). Crohn’s Disease and Axial Spondyloarthritis: From Systemic Inflammation to Amyloidosis. Journal of Clinical Medicine, 15(11), 4188. https://doi.org/10.3390/jcm15114188
Vancouver
Kutsakina DA, Chernichkina AD, Nikolaeva NA, Voronkova OO, Tashchyan OV, Mnatsakanyan MG, et al. Crohn’s Disease and Axial Spondyloarthritis: From Systemic Inflammation to Amyloidosis. Journal of Clinical Medicine. 2026;15(11):4188. doi:10.3390/jcm15114188
BibTeX
@article{Kutsakina2026,
author = {Kutsakina, Daria Alexeevna and Chernichkina, Alexandra Dmitrievna and Nikolaeva, Nadezhda Andreevna and Voronkova, Olga Olegovna and Tashchyan, Olga Valerevna and Mnatsakanyan, Marina Genrikovna and Belenkov, Yuri Nikitich and Osminin, Sergey Viktorovich and Vetshev, Fedor Petrovich and Bilyalov, Ildar Ravilievich and Panferov, Alexander Sergeevich},
title = {Crohn’s Disease and Axial Spondyloarthritis: From Systemic Inflammation to Amyloidosis},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {11},
pages = {4188},
doi = {10.3390/jcm15114188}
}
EUVIMED